FDA Supplement GMP Crosshairs More Frequently On Smaller Firms
This article was originally published in The Rose Sheet
Executive Summary
GMP violation warnings to three small dietary supplement firms in late March reflect a “thoughtful shift” by FDA toward inspections of smaller firms, says UNPA President Loren Israelsen. With the supplement GMP final rule past its 10-year anniversary, firms should be meeting their requirements.